# FDA Inspection 654293 - Baxter Pharmaceutical Solutions, LLC - March 24, 2010

Source: https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/142c7dfa-ab23-46b3-b70e-6ae59d74eae7
Source feed: FDA_Inspections

> FDA Inspection 654293 for Baxter Pharmaceutical Solutions, LLC on March 24, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 654293
- Company Name: Baxter Pharmaceutical Solutions, LLC
- Inspection Date: 2010-03-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1290838 - 2025-12-11](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/e3888c4a-f3ae-412d-ba8b-7ba36c4e3491)
- [FDA Inspection 1290838 - 2025-12-11](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/f0d97ad5-94cd-4b98-9161-ab08db98b7a2)
- [FDA Inspection 1242468 - 2024-09-24](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/5e099ee8-4e07-4b90-85f5-484e0918b190)
- [FDA Inspection 1242468 - 2024-09-24](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/5c2adc75-a229-4745-ab02-1a0b1101e671)
- [FDA Inspection 1200813 - 2023-02-17](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/eaea16ee-69c0-4bb3-9fca-7cbd0d0b5ca7)

Company: https://www.keypedia.com/companies/baxter-pharmaceutical-solutions-llc/dd8344ef-ad46-49b8-8b39-fb1d8cb518d8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d